INDOUSNSEIndo Us Biotech LimitedMediumNeutral
Announced Wed, 22 Apr · 17:18 IST

Indo Us Biotech Limited has informed the Exchange regarding Resignation of Mrs Neha Sachinbhai Patel as Non- Executive Independent Director of the company w.e.f. April 21, 2026. Revised Announcement under Reg 30 of SEBI LODR

Kmp ResignedManagement Changes View source PDF

INDOUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-4.3%1-day move
₹107.00
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-4.3-3.3-4.7-2.8-2.2-3.0-2.3-6.0-16.2-19.8
Up moveDown movePending
AI summary

Mrs. Nehaben Sachinbhai Patel has tendered her resignation as Non-Executive Independent Director of Indo Us Biotech Limited, effective 21st April, 2026. The reason stated is personal and unavoidable circumstances. She has confirmed that there are no other material reasons for her resignation beyond what was stated in her letter. Mrs. Patel does not hold any directorship in any other listed entity. The company has received her formal confirmation and the Managing Director, Mr. Jagdish Ajudiya, has signed off on the disclosure. This is a revised announcement filed under Regulation 30 of SEBI LODR following a query from the exchanges.

Likely market impact

The resignation of an Independent Director reduces board independence. While no governance red flags were raised, investors should monitor whether the company appoints a replacement to maintain compliance with board composition requirements.